Gilead Sciences, Inc. (ETR:GIS)
104.26
+1.28 (1.24%)
Feb 20, 2025, 5:35 PM CET
Gilead Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Cash & Equivalents | 9,991 | 6,085 | 5,412 | 5,338 | 5,997 | Upgrade
|
Short-Term Investments | - | 2,265 | 1,446 | 2,067 | 2,827 | Upgrade
|
Cash & Short-Term Investments | 9,991 | 8,350 | 6,858 | 7,405 | 8,824 | Upgrade
|
Cash Growth | 19.65% | 21.76% | -7.39% | -16.08% | -64.23% | Upgrade
|
Accounts Receivable | 4,420 | 4,660 | 4,777 | 4,493 | 4,892 | Upgrade
|
Receivables | 4,420 | 4,660 | 4,777 | 4,493 | 4,892 | Upgrade
|
Inventory | 3,589 | 1,787 | 1,507 | 1,618 | 1,683 | Upgrade
|
Prepaid Expenses | - | 1,281 | 1,241 | 1,181 | 585 | Upgrade
|
Other Current Assets | - | 7 | 60 | 75 | 12 | Upgrade
|
Total Current Assets | 18,000 | 16,085 | 14,443 | 14,772 | 15,996 | Upgrade
|
Property, Plant & Equipment | 5,414 | 5,898 | 5,980 | 5,663 | 5,613 | Upgrade
|
Long-Term Investments | - | 2,159 | 2,611 | 2,844 | 3,820 | Upgrade
|
Goodwill | 8,314 | 8,314 | 8,314 | 8,332 | 8,108 | Upgrade
|
Other Intangible Assets | 19,948 | 26,454 | 28,894 | 33,455 | 33,126 | Upgrade
|
Other Long-Term Assets | 7,319 | 3,215 | 2,929 | 2,886 | 1,744 | Upgrade
|
Total Assets | 58,995 | 62,125 | 63,171 | 67,952 | 68,407 | Upgrade
|
Accounts Payable | - | 550 | 905 | 705 | 844 | Upgrade
|
Accrued Expenses | - | 5,003 | 4,497 | 6,996 | 6,390 | Upgrade
|
Current Portion of Long-Term Debt | - | 1,798 | 2,273 | 1,516 | 2,757 | Upgrade
|
Current Portion of Leases | - | 125 | 111 | 101 | 107 | Upgrade
|
Current Income Taxes Payable | - | 1,208 | 959 | 539 | 598 | Upgrade
|
Other Current Liabilities | 12,004 | 2,596 | 2,492 | 1,753 | 701 | Upgrade
|
Total Current Liabilities | 12,004 | 11,280 | 11,237 | 11,610 | 11,397 | Upgrade
|
Long-Term Debt | 27,744 | 23,189 | 22,957 | 25,179 | 28,645 | Upgrade
|
Long-Term Leases | - | 546 | 467 | 489 | 608 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | 1,588 | 2,673 | 4,356 | 3,914 | Upgrade
|
Other Long-Term Liabilities | 1 | 2,773 | 4,628 | 5,254 | 5,622 | Upgrade
|
Total Liabilities | 39,749 | 39,376 | 41,962 | 46,888 | 50,186 | Upgrade
|
Common Stock | 19,246 | 1 | 1 | 1 | 1 | Upgrade
|
Additional Paid-In Capital | - | 6,500 | 5,550 | 4,661 | 3,880 | Upgrade
|
Retained Earnings | - | 16,304 | 15,687 | 16,324 | 14,381 | Upgrade
|
Comprehensive Income & Other | - | 28 | 2 | 83 | -60 | Upgrade
|
Total Common Equity | 19,246 | 22,833 | 21,240 | 21,069 | 18,202 | Upgrade
|
Minority Interest | - | -84 | -31 | -5 | 19 | Upgrade
|
Shareholders' Equity | 19,246 | 22,749 | 21,209 | 21,064 | 18,221 | Upgrade
|
Total Liabilities & Equity | 58,995 | 62,125 | 63,171 | 67,952 | 68,407 | Upgrade
|
Total Debt | 27,744 | 25,658 | 25,808 | 27,285 | 32,117 | Upgrade
|
Net Cash (Debt) | -17,753 | -16,145 | -17,705 | -18,571 | -22,791 | Upgrade
|
Net Cash Per Share | -14.15 | -12.83 | -14.03 | -14.72 | -18.05 | Upgrade
|
Filing Date Shares Outstanding | 1,246 | 1,246 | 1,247 | 1,254 | 1,257 | Upgrade
|
Total Common Shares Outstanding | 1,246 | 1,246 | 1,247 | 1,254 | 1,254 | Upgrade
|
Working Capital | 5,996 | 4,805 | 3,206 | 3,162 | 4,599 | Upgrade
|
Book Value Per Share | 15.45 | 18.33 | 17.03 | 16.80 | 14.52 | Upgrade
|
Tangible Book Value | -9,016 | -11,935 | -15,968 | -20,718 | -23,032 | Upgrade
|
Tangible Book Value Per Share | -7.24 | -9.58 | -12.81 | -16.52 | -18.37 | Upgrade
|
Land | - | 561 | 562 | 404 | 404 | Upgrade
|
Buildings | - | 4,328 | 4,390 | 3,794 | 3,678 | Upgrade
|
Machinery | - | 2,216 | 1,990 | 1,759 | 1,697 | Upgrade
|
Construction In Progress | - | 661 | 719 | 1,057 | 856 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.